Congress Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-21,600
Closed -$2.4M 363
2019
Q4
$2.4M Hold
21,600
0.03% 238
2019
Q3
$2.14M Hold
21,600
0.03% 253
2019
Q2
$2.14M Sell
21,600
-23
-0.1% -$2.19K 0.03% 264
2019
Q1
$2.38M Sell
21,623
-3,587
-14% -$375K 0.03% 258
2018
Q4
$2.32M Hold
25,210
0.03% 258
2018
Q3
$2.78M Buy
25,210
+23
+0.1% +$2.4K 0.04% 252
2018
Q2
$2.35M Hold
25,187
0.03% 254
2018
Q1
$2.09M Hold
25,187
0.03% 261
2017
Q4
$2.29M Hold
25,187
0.03% 250
2017
Q3
$1.92M Buy
+25,187
New +$1.9M 0.03% 260

Other funds holding PRAH

Congress Asset Management's PRAH Position: Q1 2020 in Review

Congress Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 21,600 shares — an estimated $2.4M sold.

Congress Asset Management first reported a position in PRAH in Q3 2017 and held it in 10 quarters. The position peaked at $2.78M in Q3 2018. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Congress Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Congress Asset Management sold 21,600 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $2.4M.
  • Congress Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 10 quarters.
  • Congress Asset Management's PRA Health Sciences, Inc. position peaked at $2.78M in Q3 2018.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Congress Asset Management's 13F filing for Q1 2020, filed 21 Apr 2020.